Danaher Corporation
Danaher Corporation Announces Shareholder Voting Results for Annual Meeting
Summary
On May 6, 2025, Danaher Corporation held its annual meeting of shareholders where several proposals were voted on. All thirteen directors were elected with majority support. The shareholders also ratified the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the year ending December 31, 2025, and approved the company's named executive officer compensation on an advisory basis. The results of the shareholder votes are as follows: Directors: All nominees were elected by majority votes ranging from 521,091,800 to 592,942,051 For votes. Ernst & Young LLP: Ratified by 599,098,858 For votes, 30,778,244 Against votes, and 1,005,417 Abstain votes. Executive Compensation: Approved by 562,800,461 For votes, 30,795,342 Against votes, and 2,887,987 Abstain votes.
Profitelligence Alerts
Get alerts for DHR
Be first to know when Danaher Corporation files with the SEC.
Filing Categories
Advertisement
About Danaher Corporation
Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.
Official SEC Documents
Advertisement